ClinicalTrials.Veeva

Menu

Utilization of Very Low Calorie Diet in Obese General Surgery Patients

Christiana Care Health Services logo

Christiana Care Health Services

Status

Completed

Conditions

Morbid Obesity

Treatments

Dietary Supplement: Very low calorie diet

Study type

Interventional

Funder types

Other

Identifiers

NCT03553849
DDD603893 / 077069243

Details and patient eligibility

About

The investigators are studying the use of a two-week very low calorie diet (VLCD) in obese general surgery patients in a randomized single-blinded trial. The investigators hypothesize that the VLCD will positively impact the perceived surgical difficulty, operative time, hospital length of stay and 30-day complications. Additionally, the investigators anticipate reduced perioperative blood glucose levels and a reduced need for perioperative insulin administration.

Full description

The investigators' objective for this project is to determine the impact of a preoperative VLCD on outcomes for patients undergoing elective general surgery. Included are patients who are obese, BMI >30, and scheduled by a Christiana Care-employed general surgeon for elective general surgery. Eligible patients are those scheduled for elective cholecystectomy, ventral or incisional hernia, umbilical hernia, and inguinal hernia surgery.

The investigators will also be determining the feasibility of introducing a preoperative VLCD for patients undergoing elective general surgery in a Community Hospital setting.

Enrollment

58 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients who are obese, BMI >30, and scheduled by a Christiana Care-employed general surgeon for elective general surgery.
  • Patients between the ages of 18 and 65.
  • Patients scheduled for elective cholecystectomy, ventral or incisional hernia, umbilical hernia, and inguinal hernia surgery.

Exclusion criteria

  • Patients will be excluded from the study if they have any of the following:

    1. Recent myocardial infarction (3-6 months).
    2. History of cerebral vascular accident (stroke).
    3. Diabetes mellitus with a history of severe ketoacidosis.
    4. Patients on SGLT2 inhibitors (glifozins) without insulin
    5. Chronic use of steroids, greater than 20mg daily.
    6. Bleeding peptic ulcer (unless there is radiological evidence of healing 6 months prior to entry).
    7. A psychiatric history that includes suicide attempts and anyone taking psychotropic drugs, including lithium carbonate.
    8. Active thrombophlebitis (or any other condition where decreased blood volume would put the patient at risk).
  • In addition, patients who are pregnant are excluded. If status is unknown, a pregnancy test will be required prior to the start of the VLCD.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

58 participants in 2 patient groups

Very Low Calorie Diet
Experimental group
Description:
If they are randomized into the treatment arm, they will be prescribed with a 2-week VLCD that will begin 2 weeks prior to the scheduled elective surgery. Patients will be required to pay for the meal replacements.
Treatment:
Dietary Supplement: Very low calorie diet
Standard Preop Diet
No Intervention group
Description:
The control group will continue a regular diet until the day before surgery.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems